Curcumin is a potent antioxidant that can neutralize free radicals in the body.
Curcumin helps reduce joint pain induced by inflammation in the joints, daily wear and tear of joints, and muscle strains.
Curcumin is a bioactive substance that fights inflammation at cellular level.
Curcumin helps in boosting immunity and helps to fight against viral replication.
The active component of turmeric that renders all its health benefits is curcumin. Turmeric contains 3 to 4% curcumin. That simply means that if you consume 1 tsp of turmeric you get an approximate of 150 to 200 mg of curcumin. To utilise its anti-inflammatory benefits, one requires at least 500 mg to 1000 mg curcumin, which can be easily achieved by supplementation.
Curcumin can be upto 95% in supplements. However, not all forms of curcumin in supplements are absorbed in the body efficiently. Therefore, sometimes you require higher doses of Curcumin supplements to notice any significant benefit from it. To address this problem, BodyFirst® Curcumin contains BioSOLVE Curcumin which has been developed with modern science to have superior solubility and eight times better bioavailability than regular curcumin powders.
This product contains a unique blend of three bioactive curcuminoids namely Curcumin, Bisdemethoxyxurcumin and Demethoxyxurcumin for promoting joint health, immunity and protection against free radical damage.
Consume one capsule post a meal
People with joint pain or arthritis.
Those who have elevated triglycerides.
Athletes or seniors with injuries or wounds.
Healthy individuals who have frequent fall ill.
Individuals suffering with lifestyle disorders.
|Sold & Marketed By||BodyFirst Wellness Nutrition Private Limited 220, Udyog Bhavan, Sonawala Lane, Goregaon - East, Mumbai, Maharashtra - 400063|
|Manufactured By||Gangwal Healthcare Pvt. Ltd. Plot No. T1, Gala 3, MIDC, Tarapur, Boisar, Opp. to Aarti Industries, Thane (Maharashtra)- 401506|
|Country of origin||INDIA|
|FSSAI License Number||10019022009712|
© BodyFirst Wellness Nutrition Private Limited 2021